Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents

Journal of the American Dental Association

Volumn 138, Issue 5, 2007, Pages 652-655

  Grines, Cindy L ^a   Bonow, Robert O ^b,c   Casey Jr , Donald E ^d   Gardner, Timothy J ^e   Lockhart, Peter B ^f   Moliterno, David J ^g   O'Gara, Patrick ^h   Whitlow, Patrick ⁱ  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Division of Cardiology

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^d Atlantic Health   (United States)

^e CHRISTIANA CARE HEALTH SYSTEM   (United States)

^f CAROLINAS MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

Author keywords

American Heart Association scientific statements; Anticoagulation therapy; Dental care; Myocardial infarction; Myocardial stunning; Stents; Thrombosis

Indexed keywords

EID: 34249657466     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0237     Document Type: Article

References (25)

1. ten Berg JM, Plokker H, Verbeugt F. Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Curr Control Trials Cardiovasc Med 2001;2(3):129-40.
2. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article - a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002;40(7):1366-74.
3. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force of Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113(7):e166-286.
4. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - endorsed by the National Heart, Lung, and Blood Institute (published correction appears in Circulation 2006;113[22]:e847). Circulation 2006;113(19):2363-72.
5. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293(19):2126-30.
6. Levine GN, Kern MJ, Berger PB, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139(2):123-36.
7. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364(9444):1519-21.
8. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45(12):2088-92.
9. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006;98(3):352-6.
10. Cutlip DE, Bairn DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103(15):1967-71.
11. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29(1):6-12.
12. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Multicenter Registry. Circulation 1996; 94(7):1519-27.
13. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109(16):1930-2.
14. Urban P, Gershlick AH, Guagliumi G, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006;113(11):1434-41.
15. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113(24):2803-9.
16. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48(12):2584-91.
17. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297(2):159-68.
18. Bhatt DL, Bertrand ME, Berger PB, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39(1):9-14.
19. U.S. Food and Drug Administration. Circulatory System Devices Panel. Available at: "www.fda.gov/ohrms/dockets/ac/cdrn06.html# circulatory". Accessed March 19, 2007.
20. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv 2005;65(4):516-9.
21. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35(5):1288-94.
22. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004;63(2):141-5.
23. Eikelboom JW, Hirsh J. Bleeding and management of bleeding. Eur Heart J 2006;8(supplement G):G38-G45.
24. Valerin MA, Brennan MT, Noll JL, et al. Relationship between aspirin use and postoperative bleeding from dental extractions in a healthy population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:326.
25. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy, part 2: coagulopathies from drugs. Br Dent J 2003;195(9):495-501.